Skip to main content
logo
Astellas Pharma Inc. (ALPMY)
OTCMKTS · Delayed Price · Currency is USD
9.69
-0.04 (-0.41%)
Jul 18, 2025, 4:00 PM EDT

Astellas Pharma Revenue

In the fiscal year ending March 31, 2025, Astellas Pharma had annual revenue of 1.91T JPY with 19.25% growth. Astellas Pharma had revenue of 459.29B in the quarter ending March 31, 2025, with 10.78% growth.

Revenue
1,912.32B JPY
Revenue Growth
+19.25%
P/S Ratio
1.37
Revenue / Employee
140.17M JPY
Employees
13,643
Market Cap
17.47B USD

Revenue Chart

* This company reports financials in JPY.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20251,912.32B308.65B19.25%
Mar 31, 20241,603.67B85.05B5.60%
Mar 31, 20231,518.62B222.46B17.16%
Mar 31, 20221,296.16B46.64B3.73%
Mar 31, 20211,249.53B-51.32B-3.94%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Endo, Inc.1.73B
Veradigm588.02M
Tian'an Technology Group1.78M
Elite Pharmaceuticals84.04M
Glass House Brands215.62M
Northwest Biotherapeutics1.47M
American Oncology Network1.76B
Silence Therapeutics27.70M
Revenue Rankings

Astellas Pharma News

More News